Our Director of Research, Dr Kieran Breen, featured in the Mar/Apr 2017 edition of Oncology News with an article highlighting the promise shown by repurposing drugs that are already in existence for the treatment of brain tumours.
We highlighted this key issue in our Invest in a Cure manifesto. The issue was also identified by the Governmental Task and Finish Group, established in response to the UK Petitions Committee's report on poor levels of funding for brain tumour research.
Read the full article here.